UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021947
Receipt number R000025312
Scientific Title A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)
Date of disclosure of the study information 2016/04/18
Last modified on 2020/12/01 22:57:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)

Acronym

A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)

Scientific Title

A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)

Scientific Title:Acronym

A randomized control trial of heparin bridging versus direct oral anticoagulant (DOAC) replacement in patients who undergo endoscopic resection for colon polyps. (NHOG-DOAC-EMR)

Region

Japan


Condition

Condition

Colon polyp

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the superiority of direct oral anticoagulant replacement to heparin bridging in post polypectomy bleeding rate for patients who undergo endoscopic resection for colon polyps.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Post polypectomy bleeding rate

Key secondary outcomes

Hospitalization, endoscopic treatment results, the rate of arterial thromboembolism, severe adverse events, endoscopic execution rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as adjustment factor in dynamic allocation.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Heparin bridging before endoscopic mucosal resection

Interventions/Control_2

direct oral anticoagulant replacement before endoscopic mucosal resection

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients who undergo endoscopic mucosal resection for colon polyps
2)Patients with non valvular atrial fibrillation, and use warfarin for prevention of thrombosis
3)PT-INR is less than 3.0
4)ages over 20 years
5)written informed consent

Key exclusion criteria

1)Plt is less than 50000/mm3
2)Patients who undergo hemodialysis
3)Woman who has a possibility of pregnancy or is during pregnancy
4)Impossible to suspend to one-antiplatelet medication.
5)The attending physician has determined that it is difficult to entry

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Takuya
Middle name
Last name Yamada

Organization

National Hospital Organization Osaka National Hospital

Division name

Gastroenterology and Hepatology

Zip code

540-0006

Address

2-1-14, Hoenzaka, Chuo-ku, Osaka

TEL

06-6942-1331

Email

yamada@onh.go.jp


Public contact

Name of contact person

1st name Takuya
Middle name
Last name Yamada

Organization

National Hospital Organization Osaka National Hospital

Division name

Gastroenterology and Hepatology

Zip code

540-0006

Address

2-1-14, Hoenzaka, Chuo-ku, Osaka

TEL

06-6942-1331

Homepage URL


Email

yamada@onh.go.jp


Sponsor or person

Institute

National Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Headquarters Clinical Research Central Ethics Review Committee

Address

2-5-21 Higashigaoka, Meguro-ku, Tokyo

Tel

03-5712-5075

Email

700-kenkyu@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構大阪医療センター(大阪府)、国立病院機構九州医療センター(福岡県)、国立病院機構呉医療センター・中国がんセンター(広島県)、国立病院機構東京医療センター(東京都)、国立病院機構三重中央医療センター(三重県)、国立病院機構災害医療センター(東京都)、国立病院機構函館病院(北海道)、国立病院機構北海道がんセンター(北海道)、国立病院機構金沢医療センター(石川県)、国立病院機構敦賀医療センター(福井県)、国立病院機構東広島医療センター(広島県)


Other administrative information

Date of disclosure of the study information

2016 Year 04 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 03 Month 04 Day

Date of IRB

2016 Year 04 Month 19 Day

Anticipated trial start date

2016 Year 05 Month 16 Day

Last follow-up date

2018 Year 05 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 17 Day

Last modified on

2020 Year 12 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025312


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name